The focus and resources of several biotech and pharma companies have shifted toward developing a vaccine or treatment for COVID-19. However, there are …
Pfizer and BioNTech announced that they have proposed the expansion of the enrollment in their Phase 3 pivotal COVID-19 vaccine trial. On September …
Johnson & Johnson and Pfizer have been in the news for the development of potential vaccines for COVID-19. According to the latest update, …
Pfizer Inc. and BioNTech SE disclosed “positive” data from an early trial of their BNT162b2 mRNA-based vaccine candidate against SARS-CoV2 and confirmed that …
Pfizer Inc. and BioNTech SE on Wednesday agreed to supply the Government of Canada with their BNT162 mRNA-based vaccine candidate against SARS-CoV2, subject to …
Pfizer Inc (PFE) and BioNTech SE (BNTX) have announced an agreement with the UK to supply 30 million doses of their BNT162 mRNA-based …
U.S.
Five companies have now been picked by the Trump administration as the most likely candidates to produce a coronavirus vaccine, The New York …
Shares in Pfizer Inc. (PFE) dropped 6% in after-market trading on Friday after the company reported a disappointing outcome for its Phase 3 …
